Abstract
Biological studies of psychiatric disease generally rely on examination of cerebrospinal fluid, blood, urine, or other tissues far removed from the brain. Indeed, metabolism in the brain is frequently so rapid that even autopsied brains, when available, shed little light on any but the most gross psychiatric or neurological disorders. Cerebrospinal fluid is physically closest to the brain. Even here, however, evidence suggests that the bulk of its composition of transmitter and transmitter metabolites comes from the local spinal cord rather than the more distant brain. The composition of blood is even more complex since it contains nutrients for and metabolites from the entire body. Similarly, urine is the repository of the entire body’s metabolic wastes and the fraction attributable to the brain is uncertain and usually indistinguishable. Due to these factors it is particularly difficult to design experiments to find significant correlations between biological measures, specific brain functions, and psychiatric syndromes. Even more difficult is the task of critically analyzing such research. One must constantly bear in mind that any differences or correlations noted may be only incidental, or due to factors unrelated to the psychiatric diagnostic categories studied.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bender, L. Childhood schizophrenia. Psychiatric Quarterly, 1953,27,663–681.
Boullin, D., Coleman, M., & O’Brien, A. Abnormalities in platelet 5-hydroxytryptamine efflux in patients with infantile autism. Nature, 1970,226, 371–372.
Boullin, D., Coleman, M., O’Brien, R., & Rimland, B. Laboratory prediction of infantile autism based on 5-hydroxytryptamine efflux from blood platelets and their correlation with the Rimland E-2 score. Journal of Autism and Childhood Schizophrenica, 1971,1, 63–71
Boullin, D., & O’Brian, R.A. Uptake and loss of 14 C-dopamine by platelets from children with infantile autism. Journal of Autism and Childhood Schizophrenia, 1972,2, 67–74.
Campbell, M., Friedman, E., Devito, E., Greenspan, L., & Collins, P. Blood serotonin in psychotic and brain damaged children. Journal of Autism and Childhood Schizophrenia, 1974,2, 33–41.
Campbell, M., Friedman, E., Green, W., Collins, P., Small, A., & Breuer, H. Blood serotonin in schizophrenic children. International Pharmacopsychology, 1975, 10, 213–221.
Campbell, M., Friedman, E., Green, W., Small, A., & Burdock, E. Blood platelets monoamine oxidase activity is schizophrenic children and their families: A preliminary study.Neuropsychobiology, in press.
Campbell, M., Small, A., Collins, P., Friedman, E., David, R., & Genieser, N. Levodopa and levoamphetamine: A crossover study in young schizophrenic children. Current Therapeutic Research, 1976,19, 70–86.
Cohen, D., Johnson, W., & Caparulo, B. Pica and elevated blood lead level in autistic and a typical Children. American Journal of Diseases of Children, 1976,130, 47–48.
Cohen, D., Shaywitz, A., Johnson, W., & Bowen, M. Biogenic amine in autistic and atypical children: Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid.Archives of General Psychiatry, 1974,31, 845–853.
Cohen, D., & Young, G. Neurochemistry and child psychiatry, in press.
Coleman, M. Serotonin and central nervous system syndromes of childhood: A review. Journal of Autism and Childhood Schizophrenia, 1973, 7, 127–135.(a)
Coleman, M. (Ed.). Serotonin in Down’s Syndrome. New York: North Holland, 1973. (b)
Coleman, M. Personal Communication, June, 1975.
Creak, M., Cameron, K., Cowie, V., Ini, S., Mac Keith, R., Mitchell, G., O’Gorman, G., Orford, F., Rogers, W., Shapiro, A., Stone, F., Stroh, G., &Yudkin, S. Schizophrenic syndrome in children. British Medical Journal, 1961,2, 889–890.
DeMyer, M., Churchill, D., Pontius, W., & Gilkey, K. A comparison of five diagnostic systems for childhood schizophrenia and infantile mtism. Journal of Autism and Childhood Schizophrenia, 1971,7, 175–189. (a)
DeMyer, M., Schwier, H., Bryson, C., Solow, E., & Roeske, N. Free fatty acid response to insulin and glucose stimulation in schizophrenic, autistic and emotionally disturbed chMxtn. Journal of Autism and Childhood Schizophrenia, 1971,4, 436–452. (b)
DeMyer, M., Ward, S., & Lintzenich, J. Comparison of macronutrients in the diets of psychotic and normal children. Archives of General Psychiatry, 1968,18, 584–590.
Fish, B. Methodology in child psychopharmacology. In D. Efron et al. (Eds.), Psychopharmacology: Review of progress. Washington, D.C.: Public Health Service, 1968.
Fowle, A. Atypical leukocyte patterns of schizophrenic children. Archives of General Psychiatry, 1968,5, 666–680.
Freeman, B., & Ritvo, E. Cognitive assessment. In E. Ritvo, B. Freeman, E. Ornitz, & P. Tanguay (eds.), Autism: Diagnosis, current research and management. Holliswood, N.Y.: Spectrum Publications, 1976.
Gittelman, M., & Cleeman, J. Serum magnesium level in psychotic and normal children. Behavioral Neuropsychiatry, 1969, 8, 51–52.
Goodwin, M., Cowen, M., & Goodwin, T. Malabsorption and cerebral dysfunction: A multivariate and comparative study of autistic children. Journal of Autism and Childhood Schizophrenia, 1971, 7, 148–162.
Heeley, A., & Roberts, G. Tryptophan metabolism in psychotic children. Developmental Medicine and Child Neurology, 1965, 7, 46–49.
Himwich, H., Jenkins, R., Fujimori, M., & Narasimachari, N. A biochemical study of early infantile mtism. Journal of Autism and Childhood Schizophrenia, 1972, 2, 114–126.
Jorgensen, S., Mellerup, E., & Rafaelsen, O. Amino acid excretion in urine of children with various psychiatric diseases: A thin layer chromatographic study. Danish Medical Bulletin, 1970, 6, 166–170.
Lucas, A., Krause, R., & Domino, E. Biological studies in childhood schizophrenia: Plasma and RBC cholinestrase activity. Journal of Autism and Childhood Schizophrenia, 1971, 7, 172–181.
Narasimachari, N., & Himwich, H. Biochemical study in early infantile autism. Biological Psychiatry, 1975, 10, 425–432.
Ornitz, E., & Ritvo, E. Perceptual inconstancy in early infantile mMsm. Archives of General Psychiatry, 1968, 18, 79–98.
Ornitz, E., & Ritvo, E. The medical diagnosis. In E. Ritvo, B. Freeman, E. Ornitz, & P. Tanguay Autism: Diagnosis, current research and management. Holliswood, N.Y.: Spectrum Publications, 1976.
Omitz, E., & Ritvo, E. The syndrome of autism: A critical review. American Journal of Psychiatry, 1911, 133, 609–621.
Rank, B. Intensive study and treatment of preschool children who show marked personality deviations of “atypical development” and their parents. In G. Caplan (Ed.), Emotional problems of early childhood. New York: Basic Books, 1955.
Rimland, B. Infantile autism. New York: Appleton-Century-Crofts, 1964.
Ritvo, E., Yuwiler, A., Geller, E., Kales, A., Rashkins, S., Schico, A., Plotkin, S., Axelrod, R., & Howard, C. Effects of L-dopa in mtism. Journal of Autism and Childhood Schizophrenia, 1971, 7, 190–205.
Ritvo, E., Yuwiler, A., Geller, E., Ornitz, E., Saeger, K., & Plotkin, S. Increased blood serotonin and platelets in early infantile autism. Archives of General Psychiatry, 1970, 23, 566–572.
Rutter, M. Autistic children-infancy to adulthood. Seminars in Psychiatry, 1970, 2, 435–450.
Rutter, M. Childhood schizophrenia reconsidered. Journal of Autism and Childhood Schizophrenia 1972, 2, 315–337.
Saladino, C., & Siva-Sankar, D. Studies on erythrocyte magnesium and potassium levels in childhood schizophrenia and growth. Behavioral Neuropsychiatry, 1969, 7, 24–28.
Schain, R., & Freedman, D. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. Journal of Pediatrics, 1961, 58, 315–320.
Schain, R., & Yannet, H. Infantile autism: An analysis of 50 cases and a consideration of certain relevant neurophysiologic concepts.Journal of Pediatrics, 1960, 57, 560–567.
Shaw, C., Lucas, J., & Rabinovitch, R. Metabolic studies in childhood schizophrenia. Effects of tryptophan loading on indole excretion. Archives of General Psychiatry, 1959, 7, 366–370.
Siva-Sankar, D. Biogenic amine uptake by blood platelets and RBC in childhood schizophrenia, Acta Paedopsychiatrica, 1970, 17, 174–182.
Siva-Sankar, D. Studies on blood platelets, blood enzymes and leucocyte chromosome breakage in childhood schizophrenia. Behavioral Neuropsychiatry, 1971,2, 11–12.
Siva-Sankar, D., Gold, E., Phipps, E., & Sankar, B. General metabolic studies on schizophrenic children. Annals of the New York Academy of Sciences, 1962, 96, 392–398.
Sutton, E., & Read, J. Abnormal amino acid metabolism in a case suggesting autism. Journal of Diseases of Children, 1958, 96, 23–28.
Yuwiler, A., Plotkin, J., Geller, E., & Ritvo, E. A rapid accurate procedure for the determination of serotonin in whole human blood. Biochemical Medicine, 1970, 5, 426–436.
Yuwiler, A., Ritvo, E., Bald, D., Kipper, D., & Koper, A. Examination of circadian rhythmicity of blood serotonin and platelets in autistic and non-autistic children.Journal of Autism and Childhood Schizophrenia, 1971, 7, 421–435.
Yuwiler, A., Ritvo, E., Geller, E., Glossman, R., Schneiderman, G., & Matsuno, D. Uptake and efflux of serotonin from platelets of autistic and nonautistic children. Journal of Autism and Childhood Schizophrenia, 1975, 5, 83–98.
Widelitz, M., & Feldman, W. Pink spot in childhood schizophrenia. Behavioral Neuropsychiatry, 1964, 1, 29–30.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Plenum Press, New York
About this chapter
Cite this chapter
Ritvo, E.R., Rabin, K., Yuwiler, A., Freeman, B.J., Geller, E. (1978). Biochemical and Hematologic Studies: A Critical Review. In: Rutter, M., Schopler, E. (eds) Autism. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-0787-7_11
Download citation
DOI: https://doi.org/10.1007/978-1-4684-0787-7_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-0789-1
Online ISBN: 978-1-4684-0787-7
eBook Packages: Springer Book Archive